rs763843966
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000492.4(CFTR):c.3808delG(p.Asp1270MetfsTer8) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,328 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000492.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.3808delG | p.Asp1270MetfsTer8 | frameshift_variant | Exon 23 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250946Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135602
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461328Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726954
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:3
This sequence change creates a premature translational stop signal (p.Asp1270Metfs*8) in the CFTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant is present in population databases (rs763843966, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of cystic fibrosis (PMID: 16980811). This variant is also known as 3940delG. ClinVar contains an entry for this variant (Variation ID: 439078). For these reasons, this variant has been classified as Pathogenic. -
The c.3808delG pathogenic mutation (also known as 3940delG), located in coding exon 23 of the CFTR gene, results from a deletion of one nucleotide at nucleotide position 3808, causing a translational frameshift with a predicted alternate stop codon (p.D1270Mfs*8). This mutation was detected in an individual with a clinical diagnosis of cystic fibrosis in conjunction with a nonsense alteration; however, phase was not confirmed (Kammesheidt A et al. Genet. Med., 2006 Sep;8:557-62). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Variant summary: CFTR c.3808delG (p.Asp1270MetfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 8e-06 in 250946 control chromosomes. c.3808delG has been reported in the literature in individuals affected with Cystic Fibrosis (Kammesheidt_2006, Ibarra-Gonzalez_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at